Adiponectin in coronary heart disease and newly diagnosed impaired glucose tolerance

Diabetes and Vascular Disease Research

Volumn 10, Issue 5, 2013, Pages 452-458

  Azizi Ghanbari, Aline ^a   Dörr, Rolf ^b   Spitzer, Stefan ^b   Stumpf, Juergen ^b   Britz, Andreas ^a   Amann Zalan, Ildiko ^c   Lodwig, Volker ^c   Ulm, Bernhard ^d   Schnell, Oliver ^d   Lohmann, Tobias ^a  

^a Municipal Hospital of Dresden Neustadt   (Germany)

^b UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^c ROCHE DIAGNOSTICS GMBH   (Germany)

^d INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

Adiponectin; coronary heart disease; diabetes mellitus; heart failure

Indexed keywords

ADIPONECTIN; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

ADIPOSE TISSUE; AGED; ANGIOCARDIOGRAPHY; ARTICLE; DIABETES MELLITUS; DOUBLE VESSEL DISEASE; ECHOCARDIOGRAPHY; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE; HEART EJECTION FRACTION; HEART FAILURE; HUMAN; HUMAN TISSUE; IMPAIRED GLUCOSE TOLERANCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NEW YORK HEART ASSOCIATION CLASS; ORAL GLUCOSE TOLERANCE TEST; SINGLE VESSEL DISEASE; TRIPLE VESSEL DISEASE; VASCULAR DISEASE; WORLD HEALTH ORGANIZATION;

ADIPONECTIN; CORONARY HEART DISEASE; DIABETES MELLITUS; HEART FAILURE;

ADIPONECTIN; AGED; AGED, 80 AND OVER; CORONARY DISEASE; DIABETES MELLITUS; FEMALE; GLUCOSE; GLUCOSE INTOLERANCE; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN;

EID: 84882354102     PISSN: 14791641     EISSN: 17528984     Source Type: Journal    
DOI: 10.1177/1479164113490179     Document Type: Article

References (30)

1. Karatergiou K, Mohamed-Ali V, Jahangiri M, et al. Adiponectin for prediction of cardiovascular risk?. Br J Diabetes Vasc Dis. 2009 ; 9: 150-154
2. Scherer PE, Williams S, Fogliano M, et al. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem. 1995 ; 270: 26746-26749
3. Hu E, Liang P, Spiegelman BM. AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem. 1996 ; 271: 10697-10703
4. Maeda K, Okubo K, Shimomura I, et al. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant gene transcript 1). Biochem Biophys Res Commun. 1996 ; 221: 286-289
5. Nakano Y, Tobe T, Choi-Miura NH, et al. Isolation and characterization of GFP28, a novel gelatin-binding protein. J Biochem. 1996 ; 120: 803-812
6. Spranger J, Kroke A, Mohlig M, et al. Adiponectin and protection against type 2 diabetes mellitus. Lancet. 2003 ; 361: 226-228
7. Ouchi N, Kihara S, Arita Y, et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation. 1999 ; 100: 2473-2476
8. Pischon T, Girman CJ, Hotamisligil GS, et al. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA. 2004 ; 291: 1730-1737
9. Wilson SR, Sabatine MS, Wiviott SD, et al. Assessment of adiponectin and the risk of recurrent cardiovascular events in patients presenting with an acute coronary syndrome: observations from the Pravastatin or atorVastatin Evaluation and Infection Trial-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22). Am Heart J. 2011 ; 161: 1147-1155
10. Lindberg S, Pedersen SH, Mogelvang R, et al. Usefulness of adiponectin as a predictor of all cause mortality in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. Am J Cardiol. 2012 ; 109: 492-496
11. Kistorp C, Faber J, Galatius S, et al. Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure. Circulation. 2005 ; 112: 1756-1762
12. Tsutamato T, Tanaka T, Sakai H, et al. Total and high molecular weight adiponectin, haemodynamics, and mortality in patients with chronic heart failure. Eur Heart J. 2007 ; 28: 1723-1730
13. Wannamethee SG, Whincup PH, Lennon L, et al. Circulating adiponectin levels and mortality in elderly men with and without cardiovascular disease and heart failure. Arch Intern Med. 2007 ; 167: 1510-1517
14. Doerr R, Hoffmann U, Otter W, et al. Oral glucose tolerance test and HbA1c for diagnosis of diabetes in patients undergoing coronary angiography. Diabetologia. 2011 ; 54: 2923-2930
15. Definition, diagnosis and classification of diabetes mellitus and its complications. Part I: diagnosis and classification of diabetes mellitus. Geneva: WHO Department of Noncommunicable Disease Surveillance ; 1999 :
16. Standards of medical care in diabetes. Diabetes Care. 2004 ; 27: S15 - S34
17. Reiber JHC, Serruys PW, Kooimann CJ, et al. Assessment of short-, medium-, and long-term variations in arterial dimensions from computer-assisted quantitation of coronary cineograms. Circulation. 1985 ; 71: 280-288
18. Hotta K, Funahashi T, Bodkin NL, et al. Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression of type 2 diabetes in rhesus monkeys. Diabetes. 2001 ; 50: 1126-1133
19. Weyer C, Funahashi T, Tanaka S, et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab. 2001 ; 86: 1930-1935
20. Von Eynatten M, Schneider JG, Humpert PM, et al. Serum adiponectin levels are an independent predictor of the extent of coronary artery disease in men. J Am Coll Cardiol. 2006 ; 47: 2124-2226
21. Zietz B, Herfarth H, Paul G, et al. Adiponectin represents an independent cardiovascular risk factor predicting HDL-cholesterol levels in type 2 diabetes. FEBS Lett. 2003 ; 545: 103-104
22. Shibata R, Ouchi N, Ito M, et al. Adiponectin-mediated modulation of hypertrophic signals in the heart. Nat Med. 2004 ; 10: 1384-1389
23. Shibata R, Izumiya Y, Sato K, et al. Adiponectin protects against the development of systolic dysfunction following myocardial function. J Mol Cell Cardiol. 2007 ; 42: 1065-1074
24. Shinmura K. Is adiponectin a bystander or a mediator in heart failure? The tangled thread of a good-natured adipokine in aging and cardiovascular disease. Heart Fail Rev. 2010 ; 15: 457-466
25. Tsukamato O, Fujita M, Kato M, et al. Natriuretic peptides enhance the production of adiponectin in human adipocytes and in patients with chronic heart failure. J Am Coll Cardiol. 2009 ; 53: 2070-2077
26. Singer JR, Palmas W, Teresi J, et al. Adiponectin and all-cause mortality in elderly people with type 2 diabetes. Diabetes Care. 2012 ; 35: 1858-1863
27. Haugen E, Furukawa Y, Isic A, et al. Increased adiponectin level in parallel with increased NT-pro BNP in patients with severe heart failure in the elderly: a hospital cohort study. Int J Cardiol. 2008 ; 125: 216-219
28. McEntegart MB, Awede B, Petrie MC, et al. Increase in serum adiponectin concentration in patients with heart failure and cachexia: relationship with leptin, other cytokines, and B-type natriuretic peptide. Eur Heart J. 2007 ; 28: 829-835
29. Ding G, Qin Q, He N, et al. Adiponectin and its receptors are expressed in adult ventricular cardiomyocytes and upregulated by activation of peroxisome proliferator-activated receptor gamma. J Mol Cell Cardiol. 2007 ; 43: 73-84
30. Pineiro R, Iglesias MJ, Gallego R, et al. Adiponectin is synthesized and secreted by human and murine cardiomyocytes. FEBS Lett. 2005 ; 579: 5163-5169